Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol

被引：0
|
作者：
Hillarp, A. [1 ]
Stadler, M. [2 ]
Haderer, C. [2 ]
Weinberger, J. [2 ]
Kessler, C. [3 ]
Roemisch, J. [2 ]
Schwartz, B. [4 ]
机构：
[1] Malmo Univ Hosp, Malmo, Sweden
[2] Octapharma PPGmbH, Vienna, Austria
[3] Georgetown Univ Hosp, Washington, DC 20007 USA
[4] Octapharma USA Inc, Hoboken, NJ USA
来源：
HAEMOPHILIA | 2011年 / 17卷 / 03期
关键词：
automated VWF:RCo assay; ristocetin cofactor; von Willebrand factor;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [31] New automated ristocetin cofactor activity assay to distinguish type 1 and type 2 von Willebrand Disease (VWD)
    Pinol, M.
    Sanchez, T.
    Sales, M.
    Vanrusselt, M.
    Arnout, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1146 - 1146
  • [32] Evaluation of an Automated von Willebrand Factor Activity Assay in von Willebrand Disease
    Trossaert, Marc
    Ternisien, Catherine
    Lefrancois, Armelle
    Llopis, Laura
    Goudemand, Jenny
    Sigaud, Marianne
    Fouassier, Marc
    Caron, Claudine
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (06) : E25 - E29
  • [33] A comparative evaluation of two new automated assays for von Willebrand factor ristocetin cofactor activity and von Willebrand factor antigen
    Stufano, F.
    Lawrie, A. S.
    La Marca, S.
    Canciani, M. T.
    Franchi, F.
    Cozzi, G.
    Baronciani, L.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 682 - 682
  • [34] Improved automated VWF:RCo assay for VWF/FVIII concentrates and plasma samples by adjustment of assay reagents, composition and performance parameters
    Stadler, M.
    Hillarp, A.
    Haderer, C.
    Zapfl, C.
    Pock, K.
    Weinberger, J.
    Roemisch, J.
    Schwartz, B.
    HAEMOPHILIA, 2009, 15 (02) : 633 - 633
  • [35] Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay
    Riddell, AF
    Jenkins, PV
    Nitu-Whalley, IC
    McCraw, AH
    Lee, CA
    Brown, SA
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) : 187 - 192
  • [36] von Willebrand factor/factor VIII concentrate (Humate-P®) is safe and effective in the prevention of perioperative bleeding in patients with very low von willebrand factor:: Ristocetin cofactor (VWF:RCo).
    Gill, Joan Cox
    Leissinger, Cindy A.
    DiPaola, Jorge
    Bernstein, Jonathan
    Ragni, Margaret V.
    Shopnick, Rinah
    Valentino, Leonard A.
    Knaub, Sigurd
    Friedman, Carl
    BLOOD, 2006, 108 (11) : 97B - 97B
  • [37] Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity
    Lasne, D.
    Dey, C.
    Dautzenberg, M. -D.
    Cherqaoui, Z.
    Monge, F.
    Aouba, A.
    Torchet, M. -F.
    Geloen, D.
    Landais, P.
    Rothschild, C.
    HAEMOPHILIA, 2012, 18 (03) : e158 - e163
  • [38] Improved automated VWF:RCo assay for VWF_FVIII concentrates and plasma samples by adjustment of assay reagents, composition and performance parameters
    Stadler, M.
    Hillarp, A.
    Haderer, C.
    Zapfl, C.
    Pock, K.
    Weinberger, J.
    Roemisch, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 528 - 528
  • [39] Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates
    Truss, N. J.
    Beavis, J.
    Maccallum, P. K.
    Harrison, P.
    Warner, T. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (07) : 1226 - 1228
  • [40] Factitious diagnosis of type 2M von Willebrand disease (VWD) with a mutation in von Willebrand factor (VWF) that affects the ristocetin cofactor assay but does not significantly affect VWF function in vivo.
    Friedman, KD
    Luhm, RA
    Scott, JP
    Maloney, KW
    Wetzel, N
    Endres, J
    Montogmery, RR
    BLOOD, 2001, 98 (11) : 536A - 536A
12345